glp-1/gip dual agonist weight loss Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Schematic illustration of monoagonists, dual

This is especially evident in mitochondrial dysfunction, which links nutrient sensing, energy production, and inflammatory stress within a single, highly integrated system

As with all things in biotech, the future is profoundly uncertain, and progress will always have roadblocks

Nature 626 , 246 (2024)

Diab Technol

Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register - an IMI-SOPHIA study

doi: 10.3389/fendo.2018.00649 Received 19 June 2018 Accepted 15 October 2018 Published 06 November 2018 Volume 9 - 2018 Edited by Marco Falasca, Curtin University, Australia Reviewed by Marta Letizia Hribal, Universit degli studi Magna Grcia di Catanzaro, Italy